Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FYX43
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,829
Award facts
- Contract value 100% obligated
- $20,829.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $20,829.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nexplanon 68 mg implants. This firm fixed-price delivery order, issued on August 25, 2025, with an ultimate completion date of September 16, 2025, represents a routine pharmaceutical procurement supporting military healthcare operations. The award carries no set-aside designation, reflecting the company's competitive standing in federal pharmaceutical markets despite its small business status.
This delivery order is issued under DMS Pharmaceutical Group's substantial Indefinite Delivery Contract with the Defense Logistics Agency valued at $499.999 billion through November 2026, which authorizes the issuance of firm fixed-price orders for comprehensive pharmaceutical products supporting military health facilities worldwide. The Nexplanon implant, a long-acting contraceptive device, falls within the extensive pharmaceutical portfolio covered by this IDC arrangement. DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain enables efficient direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites, with this delivery order exemplifying routine procurement operations under that larger contract vehicle.
Quick answers
Who was awarded contract SPE2DB25FYX43?
SPE2DB25FYX43 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FYX43 worth?
The government has obligated $20,829 on SPE2DB25FYX43.
Is contract SPE2DB25FYX43 an order under another contract?
Yes. SPE2DB25FYX43 is a delivery order under SPE2DB22D9133, an indefinite delivery contract.
Was contract SPE2DB25FYX43 competed?
The extent of competition for SPE2DB25FYX43 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award